dc.contributor.author Trzesniak, C.
dc.contributor.author McGuire, P. K.
dc.contributor.author Scazufca, M.
dc.contributor.author Menezes, P. R.
dc.contributor.author Hallak, J. E. C.
dc.contributor.author Busatto, G. F.
dc.contributor.author Schaufelberger, M. S.
dc.contributor.author Duran, F. L. S.
dc.contributor.author Santos, L. C.
dc.contributor.author Rosa, P. G. P.
dc.contributor.author Murray, R. M.
dc.contributor.author Crippa, J. A. S.
dc.date.accessioned 2025-06-13T23:47:21Z
dc.date.available 2025-06-13T23:47:21Z
dc.date.issued 2012-04-27
dc.description.abstract <jats:sec id="S0033291712000839_sec_a001"><jats:title>Background</jats:title><jats:p>Neurodevelopmental alterations have been described inconsistently in psychosis probably because of lack of standardization among studies. The aim of this study was to conduct the first longitudinal and population-based magnetic resonance imaging (MRI) evaluation of the presence and size of the cavum septum pellucidum (CSP) and adhesio interthalamica (AI) in a large sample of patients with first-episode psychosis (FEP).</jats:p></jats:sec><jats:sec id="S0033291712000839_sec_a002"><jats:title>Method</jats:title><jats:p>FEP patients (<jats:italic>n</jats:italic>=122) were subdivided into schizophrenia (<jats:italic>n</jats:italic>=62), mood disorders (<jats:italic>n</jats:italic>=46) and other psychosis (<jats:italic>n</jats:italic>=14) groups and compared to 94 healthy next-door neighbour controls. After 13 months, 80 FEP patients and 52 controls underwent a second MRI examination.</jats:p></jats:sec><jats:sec id="S0033291712000839_sec_a003" sec-type="results"><jats:title>Results</jats:title><jats:p>We found significant reductions in the AI length in schizophrenia FEP in comparison with the mood disorders and control subgroups (longer length) at the baseline assessment, and no differences in any measure of the CSP. By contrast, there was a diagnosis×time interaction for the CSP length, with a more prominent increase for this measure in the psychosis group. There was an involution of the AI length over time for all groups but no diagnosis×time interaction.</jats:p></jats:sec><jats:sec id="S0033291712000839_sec_a004" sec-type="conclusion"><jats:title>Conclusions</jats:title><jats:p>Our findings suggest that the CSP <jats:italic>per se</jats:italic> may not be linked to the neurobiology of emerging psychotic disorders, although it might be related to the progression of the disease. However, the fact that the AI length was shown to be shorter at the onset of the disorder supports the neurodevelopmental model of schizophrenia and indicates that an alteration in this grey matter junction may be a risk factor for developing psychosis.</jats:p></jats:sec>
dc.description.epage 2534
dc.description.spage 2523
dc.description.volume 42
dc.identifier.doi 10.1017/s0033291712000839
dc.identifier.issn 0033-2917
dc.identifier.issn 1469-8978
dc.identifier.openaire doi_dedup___
dc.identifier.pmid 22717008
dc.identifier.uri https://trapdev.rcub.bg.ac.rs/handle/123456789/276029
dc.openaire.affiliation King's College London
dc.openaire.collaboration 1
dc.publisher Cambridge University Press (CUP)
dc.rights CLOSED
dc.rights.license Cambridge Core User Agreement
dc.source Psychological Medicine
dc.subject Adult
dc.subject Male
dc.subject 610
dc.subject Sex Factors
dc.subject Thalamus
dc.subject Reference Values
dc.subject Risk Factors
dc.subject 616
dc.subject Image Interpretation, Computer-Assisted
dc.subject Humans
dc.subject Longitudinal Studies
dc.subject Mood Disorders
dc.subject Incidence
dc.subject Organ Size
dc.subject Magnetic Resonance Imaging
dc.subject Cross-Sectional Studies
dc.subject Psychotic Disorders
dc.subject Disease Progression
dc.subject Schizophrenia
dc.subject Female
dc.subject Septum Pellucidum
dc.subject Brazil
dc.subject.fos 03 medical and health sciences
dc.subject.fos 0302 clinical medicine
dc.title Longitudinal follow-up of cavum septum pellucidum and adhesio interthalamica alterations in first-episode psychosis: a population-based MRI study
dc.type publication

Collections

Loading...